Favorable News On Keytruda Drives Piper Jaffray's Upgrade Of Merck

By: via Benzinga
After the close on Wednesday, Merck & Co., Inc. (NYSE: MRK) announced that the FDA had accepted its filing for Keytruda based on the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.